← All organizations

Morphotek

For profit

Also known as: Morphotek Clinical Development Section, JAC PCU

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2005

Last known activity

Nov 4, 2015

Acquired by EisaiSarepta Therapeutics on Apr 19, 2007

Timeline

2000s

  1. Jan 1, 2000

    Morphotek— Founded

  2. Apr 19, 2007

    Eisai— Acquired By

2010s

  1. Mar 4, 2011

    TransMolecular— Acquired

  2. Jan 1, 2014

    Sarepta Therapeutics— Now

Drugs by trial phase (15 distinct, 30 trials)

Indications

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (34)

Details

Founded
Exton, PA, US Jan 1, 2000
Last known activity
Nov 4, 2015